Research progress on the disease burden of pneumoconiosis in China.
10.3760/cma.j.cn121094-20211115-00562
- Author:
He Ren LOU
1
;
Xin WANG
2
Author Information
1. School of Public Health, Tianjin Medical University, Tianjin 300070, China Institute for Occupational Health, Tianjin Center for Disease Control and Prevention, Tianjin 300011, China.
2. Institute for Occupational Health, Tianjin Center for Disease Control and Prevention, Tianjin 300011, China.
- Publication Type:Journal Article
- Keywords:
Cost-benefit analysis;
Disability adjusted life years (DALY);
Disease burden;
Economic burden;
Pneumoconiosis
- MeSH:
Humans;
Pneumoconiosis/epidemiology*;
Occupational Diseases;
China/epidemiology*;
Cost of Illness
- From:
Chinese Journal of Industrial Hygiene and Occupational Diseases
2023;41(2):155-160
- CountryChina
- Language:Chinese
-
Abstract:
Pneumoconiosis is the largest and most serious disease among the legal occupational diseases in China, which causes long-term heavy disease burden to individuals, enterprises and society. How to scientifically and reasonably measure and reduce the health impact and economic loss caused by pneumoconiosis has become a key and difficult research topic. In recent years, with the development of global burden of disease (GBD) research, some scholars have adopted disease burden index to evaluate the disease burden of pneumoconiosis, but the research results and data are relatively independent, and there is a lack of systematic evaluation system and framework. This paper summarized the application of disease burden assessment index for pneumoconiosis, epidemiological and economic burden of pneumoconiosis, and the cost-effectiveness of reducing the burden. This paper aims to understand the present situation of pneumoconiosis disease burden in our country, discover the problems and challenges of pneumoconiosis disease burden research in our country now. It provides scientific basis for the research and application of pneumoconiosis and other occupational disease burden in China, as well as the formulation of comprehensive intervention measures, optimization of health resources allocation and reduction of disease burden.
